iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes

Type 1 Diabetes Clinical Trial

Official title:

iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06348160
• Other study ID #: STUDY20230187
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 1, 2024
• Est. completion date: March 31, 2026

Study information

• Verified date: March 2024
• Source: University Hospitals Cleveland Medical Center
• Contact: Dionne Williams, PhD
• Phone: (216) 238-6100
• Email: Dionne.Williams[@]UHhospitals.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This research study aims to test a financial and health insurance iHERO Toolkit for young adults with type1 diabetes. The iHERO Toolkit was developed over one year with the type 1 diabetes community, The Diabetes Link organization, and experts. Now, the investigators want to understand the impact of the iHERO Toolkit on diabetes self-management, financial stress, and health insurance literacy outcomes. The investigators are doing this study because it will help to better understand how to support health insurance and financial stress and improve self-management outcomes in young adults with type 1 diabetes. The investigators want to understand how the iHERO Toolkit helps all young adults with diabetes, but especially those on Medicaid and who are racially or ethnically diverse. The investigators will ask participants to participate at four-time points over one year. For the first time, participants will fill out online enrollment and demographic forms and 9 surveys. The 9 surveys have 8-40 short questions each, estimated to take about 45 minutes. Participants will also be asked to complete a home A1c collection with a University Hospitals team member on Zoom.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 192
• Est. completion date: March 31, 2026
• Est. primary completion date: March 31, 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• Age range: 18-30 years
• Diagnosis of type 1 diabetes (T1D)
• T1D duration for one year or longer
• Geographical location: residing in the United States.

Exclusion Criteria:

• Inability to answer questions due to cognitive status.
• Inability to read or understand English.
• Diagnosis of insulin-dependent diabetes that is not T1D such as cystic fibrosis-related diabetes, maturity-onset diabetes of the young, or insulin-dependent type 2 diabetes.

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus, Type 1
• Type 1 Diabetes

Intervention

Behavioral:
• iHERO Toolkit Resource
iHERO Toolkit consists of micro-videos and supplemental online resources. Participants will have access to the toolkit housed on pathfactory for 30 days.

Locations

Country	Name	City	State
United States	University Hospitals	Cleveland	Ohio
United States	University of Florida Diabetes Institute	Gainesville	Florida
United States	Children's Hospital Los Angeles	Los Angeles	California
United States	Children's Hospital of Philadelphia	Philadelphia	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
Julia Blanchette	The Leona M. and Harry B. Helmsley Charitable Trust

Country where clinical trial is conducted

United States, 

References & Publications (2)

Blanchette JE, Allen NA, Litchman ML. The Feasibility and Acceptability of a Community-Developed Health Insurance and Financial Toolkit for Emerging Adults With Type 1 Diabetes. Sci Diabetes Self Manag Care. 2022 Jun;48(3):174-183. doi: 10.1177/26350106221087474. Epub 2022 Mar 15. — View Citation

Blanchette JE, Toly VB, Wood JR. Financial stress in emerging adults with type 1 diabetes in the United States. Pediatr Diabetes. 2021 Aug;22(5):807-815. doi: 10.1111/pedi.13216. Epub 2021 May 18. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in financial stress as measured by the Personal Financial Well-Being Scale© (PFW) Scale (PFW)	The PFW is an 8-item scale used to measure financial stress with a Likert scale of 1-10 with 1 being no financial stress and 10 being an overwhelming level of financial stress. Lower scores (= 4.4) indicate high financial stress, while scores ranging from 4.5-6.4 indicate average stress, and scores = 6.5 indicate low stress.	Baseline, 1 month, 6 months, 12 months
Primary	Change in health insurance literacy as measured by The Health Insurance Literacy Measure (HILM) Measure (HILM)	The HILM is a 21-item measure used to rate confidence in selecting and using health insurance with 0 representing little confidence and 4 representing highest confidence. The scores of the items are summed and range from 0 to 84, with higher scores representing greater levels of health insurance literacy.	Baseline, 1 month, 6 months, 12 months
Primary	Change in diabetes-specific quality of life as measured by The Type 1 Diabetes and Life Young Adult (T1DAL- Young Adult) for ages 18-25 or The Type 1 Diabetes and Life (T1DAL- Adult) for Ages 26-30.	T1DAL-Young Adult and T1DAL- Adult are scored on a scale of 0-100 with higher scores indicating better health related quality of life.	Baseline, 1 month, 6 months, 12 months
Primary	Change in transition navigation readiness as measured by the The Readiness for Emerging Adults with Diabetes Diagnosed in Youth (READDY) Navigation Subscale	READDY navigation sub-scale scores of 1-3 indicate lower levels of confidence and scores of 4-5 indicate higher levels of confidence in healthcare navigation.	Baseline, 1 month, 6 months, 12 months
Primary	Change in HbA1c levels as measured by self-collect capillary HbA1c		Baseline, 6 months, 12 months